Found 73 matching trials
Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF) PHASE1 The purpose of this study is to evaluate the safety and effectiveness of co...
Show More Location
Central Hematology Oncology Medical Group, Inc.
Learn More & Join Trial
Study of Neoadjuvant Chemotherapy of Breast Cancer PHASE2 The purpose of this study is to evaluate the pathological CR rate in breast...
Show More Location
Auxilio Mutuo Cancer Center
Learn More & Join Trial
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing PHASE2 Patients with salivary gland carcinoma were divided into groups according t...
Show More Learn More & Join Trial
RC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II Study PHASE2 This multicenter, Phase II study (RADIANT-BC01) evaluates the efficacy and ...
Show More Location
The First Affiliated Hospital with Nanjing Medical University
Learn More & Join Trial
A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast Cancer PHASE2 Multicenter randomised phase II study of neoadjuvant therapy in HER2 positi...
Show More Location
Paracelsus Medical University Salzburg-Oncology, Coop. Group
Learn More & Join Trial
Neoadjuvant Treatment of Breast Cancer PHASE2 Study Aims
1. To measure the clinic response rates in patients with breast...
Show More Location
Chao Family Comprehensive Cancer Center
Learn More & Join Trial
Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer PHASE2 Pilot, phase II, parallel-group, open-label, noncomparative, prospective, m...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast Cancer PHASE2 This is a phase IIb, randomized, parallel-group, noncomparative, multicente...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab PHASE2 The purpose of this phase II is to study the efficacy and toxicity of carbo...
Show More Status
Active Not Recruiting
Location
UC Irvine Health/Chao Family Comprehensive Cancer Center
Learn More & Join Trial
Bevacizumab in Multiple Phase I Combinations PHASE1 The goal of this clinical research study is to find the highest tolerable d...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial